F. M. Klenke, D. E. Wenger, C. Y. Inwards, P. S. Rose and F. H. Sim, “Giant Cell Tumor of bone: Risk Factors for Recurrence,” Clinical Orthopaedics and Related Re-search, Vol. 469, No. 2, February 2011, pp. 591-599. doi:10.1007/s11999-010-1501-7

has been cited by the following article:

• TITLE: The surgical Treatment and Outcome of Pathological Fracture in Patients with Giant Cell Tumor of Bone

  AUTHORS: Tomoaki Torigoe, Atsuhiko Terakado, Yoshiyuki Suehara, Taketo Okubo, Tatsuya Takagi, Kazuo Kaneko, Yasuo Yazawa

  KEYWORDS: Giant Cell Tumor of Bone, Pathological Fracture

  JOURNAL NAME: Surgical Science, Vol.2 No.5, July 29, 2011

  ABSTRACT: Between 1992 and 2008, we treated 35 patients with giant cell tumor (GCT) of bone, seven of the 35 pre-sented with a pathological fracture. The fractures were located in the femur in five, and in the humerus and radius in one patient each. The surgical treatments were curettage in six cases and wide resection in the distal radius case. Two of the seven patients developed local recurrence, giving a local recurrence rate of 29%. The local recurrence rate in GCT patients without a pathological fracture was 21%. There was a tendency for there to be a higher recurrence rate associated with fractured GCT, but no statistically significant difference was observed between the two groups. Therefore, it was considered that a pathological fracture was not a risk factor for local recurrence in GCT.